24EL-462: On-Demand Hot Topic Discussion: Ensuring Blood Safety and Protecting Public Health: Navigating Emerging Infectious Diseases

Credits
1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP)

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, August 7, 2024
Program Number: 24EL-462

Faculty
(affiliations at the time of the live program)

Moderator: Karen Palmer, MT(ASCP) CQA(ASQ), Director, Regulatory Affairs, AABB
Speakers: Louis Katz, MD, Impact Life; Jed Gorlin, MD, Innovative Blood; Pallavi Annambhotla, DrPH, Centers for Disease Control and Prevention; Kelley Garner, MPH, MLS(ASCP)CM, Arkansas Department of Health; Steven Drews, PhD, FCCM(ABMM), Canadian Blood Service; Sharon Carayiannis, MT(ASCP)HP, AABB

Program Description
Join us as we provide context for the recently (February 2024) published AABB Emerging Infectious Diseases (EID) Fact Sheets. Last published in 2009, these highly cited Fact Sheets describe 72 infectious agents in detail (including, but not limited to, respiratory and sexually transmitted diseases), include background information about each agent, assessments of the agent’s clinical features and characteristics specifically related to transfusion transmission, and potential interventions amongst others.

Learning Objectives
After participating in this educational activity, participants should be able to:

  • Comprehend AABB and the TTD Committee's Role: Describe AABB, the responsibilities of the AABB Transfusion Transmitted Disease (TTD) Committee, and their overarching charges related to blood safety, and the global importance of the Emerging Infectious Disease (EID) Fact Sheets.
  • Monitor and Assess Emerging Threats: Explain how emerging threats to blood safety are monitored and assessed by the TTD Committee, the development and maintenance of the EID Fact Sheets, distinguish between RTTIs (Relevant Transfusion-Transmitted Infections) and other emerging threats, and identify recent trends and emerging pathogens that pose risks to blood safety.
  • Recognize the Importance of Communication and International Perspectives: Describe the critical importance of monitoring emerging infectious diseases in transfusion medicine, the significance of communication and collaboration between blood centers and public health departments and recognize the unique perspectives and approaches from the Canadian viewpoint regarding emerging infectious diseases and blood safety.

Moderator

Speaker Image for Karen Palmer
Karen Palmer, MT(ASCP), CQA(ASQ)
Director, Regulatory Affairs, AABB

Speakers

Speaker Image for Lou Katz
Impact Life
Speaker Image for Jed Gorlin
Jed B. Gorlin, MD, MBA
Innovative Blood
Speaker Image for Pallavi Annambhotla
Centers for Disease Control and Prevention
Speaker Image for Kelley Garner
Kelley Garner, MPH, MLS(ASCP)
Arkansas Department of Health
Speaker Image for Steven Drews
Steven J. Drews, PhD, FCCM, D(ABMM)
Donation Policy and Studies, Canadian Blood Services; Professor, Division of Diagnostic and Applied Microbiology, University of Alberta, Edmonton, AB, Canada.
Speaker Image for Sharon Carayiannis
Sharon Carayiannis, MT(ASCP)HP
Vice President, Accreditation, Standards & Quality, AABB

Related Products

Thumbnail for AM23-ST-09-O: Lean is the Enemy of Preparedness: Analysis of Contribution of Supply Chain Shortages Affecting Blood Supply for Transfusion Medicine (Enduring)
AM23-ST-09-O: Lean is the Enemy of Preparedness: Analysis of Contribution of Supply Chain Shortages Affecting Blood Supply for Transfusion Medicine (Enduring)
We have experienced a record number of supply chain failures adversely affecting the national blood supply, including whole blood collection bags, apheresis collection kits, and solutions like calcium chloride…
Thumbnail for AM24-MN-27-O: Ask the FDA and CMS/CLIA (Enduring)
AM24-MN-27-O: Ask the FDA and CMS/CLIA (Enduring)
This popular session consistently draws a large audience and provides an opportunity for the regulatory experts with the Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services/Clinical Laboratory Improvement Amendments representatives to respond to member questions abou…
Thumbnail for AM23-TU-07-O: HOT TOPIC - Individual Donor Assessment (Enduring)
AM23-TU-07-O: HOT TOPIC - Individual Donor Assessment (Enduring)
On May 11, 2023, the U.S. Food and Drug Administration (FDA) released a highly anticipated final guidance that recommends the adoption of individual donor assessment (IDA) to determine blood donor eligibility…
Thumbnail for AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring)
AM24-MN-35-O: The Role of Blood Operators and Transfusion Services in Preventing and Responding to Transfusion-transmitted Malaria (Enduring)
Malaria is caused by intra erythrocytic parasites from the genus Plasmodium. In the natural world, Plasmodium is transmitted to humans via the bite of an infected female Anopheles mosquito…